uuid stringlengths 4 8 | template_uuid stringclasses 40
values | question stringlengths 13 193 | answer stringlengths 29 2.2k | benchmark_query stringlengths 133 622 | execution_results stringlengths 2 1.14M | query_type stringclasses 2
values | sql_category stringclasses 26
values | bio_category stringclasses 14
values |
|---|---|---|---|---|---|---|---|---|
Q3.691 | Q3 | What is the allele frequency of the SNP rs530391854 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs530391854 has an effect allele TA frequency of 0.0048 and non-effect allele T frequency of 0.9952. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs530391854'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_7280351', 'SNP': 'rs530391854', 'effect_allele': 'TA', 'effect_allele_frequency': 0.0048, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9952}] | general | Select, Calculate | Allele Frequency |
Q3.36 | Q3 | What is the allele frequency of the SNP rs189783021 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs189783021 has an effect allele T frequency of 0.0021 and non-effect allele C frequency of 0.9979. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs189783021'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_431031', 'SNP': 'rs189783021', 'effect_allele': 'T', 'effect_allele_frequency': 0.0021, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9979}] | general | Select, Calculate | Allele Frequency |
Q3.910 | Q3 | What is the allele frequency of the SNP rs2965556 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs2965556 has an effect allele G frequency of 0.2121 and non-effect allele A frequency of 0.7879. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs2965556'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_9767166', 'SNP': 'rs2965556', 'effect_allele': 'G', 'effect_allele_frequency': 0.2120999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.7879}] | general | Select, Calculate | Allele Frequency |
Q3.834 | Q3 | What is the allele frequency of the SNP rs114591714 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs114591714 has an effect allele C frequency of 0.001 and non-effect allele T frequency of 0.999. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs114591714'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_8901206', 'SNP': 'rs114591714', 'effect_allele': 'C', 'effect_allele_frequency': 0.001, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.999}] | general | Select, Calculate | Allele Frequency |
Q3.1798 | Q3 | What is the allele frequency of the SNP rs9953556 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs9953556 has an effect allele T frequency of 0.0012 and non-effect allele C frequency of 0.9988. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs9953556'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_19204526', 'SNP': 'rs9953556', 'effect_allele': 'T', 'effect_allele_frequency': 0.0012, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9988}] | general | Select, Calculate | Allele Frequency |
Q3.413 | Q3 | What is the allele frequency of the SNP rs11128072 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs11128072 has an effect allele T frequency of 0.4566 and non-effect allele C frequency of 0.5434. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs11128072'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_4224824', 'SNP': 'rs11128072', 'effect_allele': 'T', 'effect_allele_frequency': 0.4566, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.5434}] | general | Select, Calculate | Allele Frequency |
Q3.928 | Q3 | What is the allele frequency of the SNP rs139272524 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs139272524 has an effect allele A frequency of 0.3891 and non-effect allele G frequency of 0.6109. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs139272524'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_9908802', 'SNP': 'rs139272524', 'effect_allele': 'A', 'effect_allele_frequency': 0.3891, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.6109}] | general | Select, Calculate | Allele Frequency |
Q3.543 | Q3 | What is the allele frequency of the SNP rs55886014 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs55886014 has an effect allele G frequency of 0.2711 and non-effect allele A frequency of 0.7289. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs55886014'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_5657485', 'SNP': 'rs55886014', 'effect_allele': 'G', 'effect_allele_frequency': 0.2711, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.7289}] | general | Select, Calculate | Allele Frequency |
Q3.765 | Q3 | What is the allele frequency of the SNP rs535463055 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs535463055 has an effect allele A frequency of 0.0031 and non-effect allele G frequency of 0.9969. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs535463055'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_8047724', 'SNP': 'rs535463055', 'effect_allele': 'A', 'effect_allele_frequency': 0.0031, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9969}] | general | Select, Calculate | Allele Frequency |
Q3.1905 | Q3 | What is the allele frequency of the SNP rs2038893 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs2038893 has an effect allele A frequency of 0.4056 and non-effect allele G frequency of 0.5944. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs2038893'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_20402530', 'SNP': 'rs2038893', 'effect_allele': 'A', 'effect_allele_frequency': 0.4056, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.5944}] | general | Select, Calculate | Allele Frequency |
Q3.1071 | Q3 | What is the allele frequency of the SNP rs552450876 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs552450876 has an effect allele C frequency of 0.0007 and non-effect allele G frequency of 0.9993. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs552450876'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_11405032', 'SNP': 'rs552450876', 'effect_allele': 'C', 'effect_allele_frequency': 0.0007, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9993}] | general | Select, Calculate | Allele Frequency |
Q3.1209 | Q3 | What is the allele frequency of the SNP rs3011598 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs3011598 has an effect allele A frequency of 0.2848 and non-effect allele G frequency of 0.7152. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs3011598'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_12895222', 'SNP': 'rs3011598', 'effect_allele': 'A', 'effect_allele_frequency': 0.2848, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.7152000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.248 | Q3 | What is the allele frequency of the SNP rs552956174 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs552956174 has an effect allele T frequency of 0.0008 and non-effect allele C frequency of 0.9992. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs552956174'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_2470360', 'SNP': 'rs552956174', 'effect_allele': 'T', 'effect_allele_frequency': 0.0008, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9992}] | general | Select, Calculate | Allele Frequency |
Q3.1431 | Q3 | What is the allele frequency of the SNP rs76972405 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs76972405 has an effect allele G frequency of 0.0093 and non-effect allele A frequency of 0.9907. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs76972405'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_15166045', 'SNP': 'rs76972405', 'effect_allele': 'G', 'effect_allele_frequency': 0.0092999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9907000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.1137 | Q3 | What is the allele frequency of the SNP rs10813871 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs10813871 has an effect allele G frequency of 0.2542 and non-effect allele T frequency of 0.7458. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs10813871'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_12020833', 'SNP': 'rs10813871', 'effect_allele': 'G', 'effect_allele_frequency': 0.2542, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.7458}] | general | Select, Calculate | Allele Frequency |
Q3.791 | Q3 | What is the allele frequency of the SNP rs900126042 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs900126042 has an effect allele G frequency of 0.0004 and non-effect allele T frequency of 0.9996. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs900126042'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_8366997', 'SNP': 'rs900126042', 'effect_allele': 'G', 'effect_allele_frequency': 0.0003999999999999, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9996000000000002}] | general | Select, Calculate | Allele Frequency |
Q3.1744 | Q3 | What is the allele frequency of the SNP rs17562828 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs17562828 has an effect allele A frequency of 0.1599 and non-effect allele G frequency of 0.8401. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs17562828'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_18554899', 'SNP': 'rs17562828', 'effect_allele': 'A', 'effect_allele_frequency': 0.1599, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.8401000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.495 | Q3 | What is the allele frequency of the SNP rs569480203 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs569480203 has an effect allele G frequency of 0.0005 and non-effect allele A frequency of 0.9995. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs569480203'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_5203943', 'SNP': 'rs569480203', 'effect_allele': 'G', 'effect_allele_frequency': 0.0004999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9995}] | general | Select, Calculate | Allele Frequency |
Q3.157 | Q3 | What is the allele frequency of the SNP rs73087695 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs73087695 has an effect allele C frequency of 0.0024 and non-effect allele T frequency of 0.9976. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs73087695'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_1504644', 'SNP': 'rs73087695', 'effect_allele': 'C', 'effect_allele_frequency': 0.0023999999999999, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9976000000000002}] | general | Select, Calculate | Allele Frequency |
Q3.970 | Q3 | What is the allele frequency of the SNP rs566263729 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs566263729 has an effect allele C frequency of 0.0017 and non-effect allele T frequency of 0.9983. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs566263729'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_10420527', 'SNP': 'rs566263729', 'effect_allele': 'C', 'effect_allele_frequency': 0.0017, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9983}] | general | Select, Calculate | Allele Frequency |
Q3.860 | Q3 | What is the allele frequency of the SNP rs1738569 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs1738569 has an effect allele T frequency of 0.4529 and non-effect allele A frequency of 0.5471. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs1738569'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_9130358', 'SNP': 'rs1738569', 'effect_allele': 'T', 'effect_allele_frequency': 0.4528999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.5471000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.1325 | Q3 | What is the allele frequency of the SNP rs1047727922 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs1047727922 has an effect allele T frequency of 0.0008 and non-effect allele C frequency of 0.9992. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs1047727922'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_14047781', 'SNP': 'rs1047727922', 'effect_allele': 'T', 'effect_allele_frequency': 0.0008, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9992}] | general | Select, Calculate | Allele Frequency |
Q3.632 | Q3 | What is the allele frequency of the SNP rs293103 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs293103 has an effect allele T frequency of 0.4921 and non-effect allele C frequency of 0.5079. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs293103'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_6596714', 'SNP': 'rs293103', 'effect_allele': 'T', 'effect_allele_frequency': 0.4921, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.5079}] | general | Select, Calculate | Allele Frequency |
Q3.692 | Q3 | What is the allele frequency of the SNP rs149971516 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs149971516 has an effect allele G frequency of 0.0073 and non-effect allele C frequency of 0.9927. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs149971516'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_7291899', 'SNP': 'rs149971516', 'effect_allele': 'G', 'effect_allele_frequency': 0.0072999999999999, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9927000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.1562 | Q3 | What is the allele frequency of the SNP rs555973334 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs555973334 has an effect allele C frequency of 0.0004 and non-effect allele T frequency of 0.9996. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs555973334'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_16696110', 'SNP': 'rs555973334', 'effect_allele': 'C', 'effect_allele_frequency': 0.0003999999999999, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9996000000000002}] | general | Select, Calculate | Allele Frequency |
Q3.575 | Q3 | What is the allele frequency of the SNP rs112115802 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs112115802 has an effect allele C frequency of 0.0049 and non-effect allele G frequency of 0.9951. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs112115802'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_5934430', 'SNP': 'rs112115802', 'effect_allele': 'C', 'effect_allele_frequency': 0.0049, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9951}] | general | Select, Calculate | Allele Frequency |
Q3.1909 | Q3 | What is the allele frequency of the SNP rs75407362 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs75407362 has an effect allele T frequency of 0.0046 and non-effect allele C frequency of 0.9954. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs75407362'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_20420369', 'SNP': 'rs75407362', 'effect_allele': 'T', 'effect_allele_frequency': 0.0046, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9954}] | general | Select, Calculate | Allele Frequency |
Q3.18 | Q3 | What is the allele frequency of the SNP rs575981866 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs575981866 has an effect allele T frequency of 0.0017 and non-effect allele C frequency of 0.9983. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs575981866'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_284708', 'SNP': 'rs575981866', 'effect_allele': 'T', 'effect_allele_frequency': 0.0017, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9983}] | general | Select, Calculate | Allele Frequency |
Q3.130 | Q3 | What is the allele frequency of the SNP rs560817431 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs560817431 has an effect allele G frequency of 0.0025 and non-effect allele A frequency of 0.9975. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs560817431'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_1305302', 'SNP': 'rs560817431', 'effect_allele': 'G', 'effect_allele_frequency': 0.0024999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9975}] | general | Select, Calculate | Allele Frequency |
Q3.1361 | Q3 | What is the allele frequency of the SNP rs557147209 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs557147209 has an effect allele A frequency of 0.0016 and non-effect allele G frequency of 0.9984. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs557147209'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_14410264', 'SNP': 'rs557147209', 'effect_allele': 'A', 'effect_allele_frequency': 0.0016, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9984}] | general | Select, Calculate | Allele Frequency |
Q3.1291 | Q3 | What is the allele frequency of the SNP rs545480865 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs545480865 has an effect allele T frequency of 0.0018 and non-effect allele C frequency of 0.9982. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs545480865'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_13654767', 'SNP': 'rs545480865', 'effect_allele': 'T', 'effect_allele_frequency': 0.0018, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9982}] | general | Select, Calculate | Allele Frequency |
Q3.1969 | Q3 | What is the allele frequency of the SNP rs112937747 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs112937747 has an effect allele T frequency of 0.0013 and non-effect allele C frequency of 0.9987. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs112937747'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_20927175', 'SNP': 'rs112937747', 'effect_allele': 'T', 'effect_allele_frequency': 0.0013, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9987}] | general | Select, Calculate | Allele Frequency |
Q3.935 | Q3 | What is the allele frequency of the SNP rs17866845 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs17866845 has an effect allele C frequency of 0.0009 and non-effect allele T frequency of 0.9991. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs17866845'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_10016042', 'SNP': 'rs17866845', 'effect_allele': 'C', 'effect_allele_frequency': 0.0009, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9991}] | general | Select, Calculate | Allele Frequency |
Q3.989 | Q3 | What is the allele frequency of the SNP rs75753617 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs75753617 has an effect allele C frequency of 0.165 and non-effect allele G frequency of 0.835. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs75753617'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_10598656', 'SNP': 'rs75753617', 'effect_allele': 'C', 'effect_allele_frequency': 0.165, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.835}] | general | Select, Calculate | Allele Frequency |
Q3.1965 | Q3 | What is the allele frequency of the SNP rs149504688 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs149504688 has an effect allele A frequency of 0.0004 and non-effect allele G frequency of 0.9996. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs149504688'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_20892662', 'SNP': 'rs149504688', 'effect_allele': 'A', 'effect_allele_frequency': 0.0004, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9996}] | general | Select, Calculate | Allele Frequency |
Q3.193 | Q3 | What is the allele frequency of the SNP rs11898131 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs11898131 has an effect allele A frequency of 0.0014 and non-effect allele G frequency of 0.9986. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs11898131'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_1916586', 'SNP': 'rs11898131', 'effect_allele': 'A', 'effect_allele_frequency': 0.0014, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9986}] | general | Select, Calculate | Allele Frequency |
Q3.1149 | Q3 | What is the allele frequency of the SNP rs10869981 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs10869981 has an effect allele T frequency of 0.0138 and non-effect allele C frequency of 0.9862. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs10869981'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_12139317', 'SNP': 'rs10869981', 'effect_allele': 'T', 'effect_allele_frequency': 0.0138, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9862}] | general | Select, Calculate | Allele Frequency |
Q3.1001 | Q3 | What is the allele frequency of the SNP rs11988463 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs11988463 has an effect allele T frequency of 0.1462 and non-effect allele C frequency of 0.8538. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs11988463'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_10705536', 'SNP': 'rs11988463', 'effect_allele': 'T', 'effect_allele_frequency': 0.1462, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.8538}] | general | Select, Calculate | Allele Frequency |
Q3.1956 | Q3 | What is the allele frequency of the SNP rs550026014 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs550026014 has an effect allele C frequency of 0.0008 and non-effect allele T frequency of 0.9992. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs550026014'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_20830929', 'SNP': 'rs550026014', 'effect_allele': 'C', 'effect_allele_frequency': 0.0008, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9992}] | general | Select, Calculate | Allele Frequency |
Q3.1657 | Q3 | What is the allele frequency of the SNP rs138558179 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs138558179 has an effect allele G frequency of 0.0101 and non-effect allele C frequency of 0.9899. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs138558179'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_17703490', 'SNP': 'rs138558179', 'effect_allele': 'G', 'effect_allele_frequency': 0.0100999999999999, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9899000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.613 | Q3 | What is the allele frequency of the SNP rs6855375 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs6855375 has an effect allele T frequency of 0.0084 and non-effect allele A frequency of 0.9916. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs6855375'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_6337759', 'SNP': 'rs6855375', 'effect_allele': 'T', 'effect_allele_frequency': 0.0083999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9916000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.183 | Q3 | What is the allele frequency of the SNP rs3771148 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs3771148 has an effect allele T frequency of 0.3897 and non-effect allele C frequency of 0.6103. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs3771148'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_1775541', 'SNP': 'rs3771148', 'effect_allele': 'T', 'effect_allele_frequency': 0.3897, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.6103000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.305 | Q3 | What is the allele frequency of the SNP rs183487684 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs183487684 has an effect allele C frequency of 0.0022 and non-effect allele G frequency of 0.9978. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs183487684'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_3056471', 'SNP': 'rs183487684', 'effect_allele': 'C', 'effect_allele_frequency': 0.0022, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9978}] | general | Select, Calculate | Allele Frequency |
Q3.502 | Q3 | What is the allele frequency of the SNP rs570532932 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs570532932 has an effect allele C frequency of 0.0016 and non-effect allele G frequency of 0.9984. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs570532932'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_5270842', 'SNP': 'rs570532932', 'effect_allele': 'C', 'effect_allele_frequency': 0.0016, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9984}] | general | Select, Calculate | Allele Frequency |
Q3.1696 | Q3 | What is the allele frequency of the SNP rs183302642 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs183302642 has an effect allele T frequency of 0.0026 and non-effect allele C frequency of 0.9974. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs183302642'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_18049174', 'SNP': 'rs183302642', 'effect_allele': 'T', 'effect_allele_frequency': 0.0026, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9974}] | general | Select, Calculate | Allele Frequency |
Q3.1721 | Q3 | What is the allele frequency of the SNP rs114172480 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs114172480 has an effect allele C frequency of 0.0039 and non-effect allele T frequency of 0.9961. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs114172480'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_18254447', 'SNP': 'rs114172480', 'effect_allele': 'C', 'effect_allele_frequency': 0.0039, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9961}] | general | Select, Calculate | Allele Frequency |
Q3.1662 | Q3 | What is the allele frequency of the SNP rs73471216 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs73471216 has an effect allele A frequency of 0.0011 and non-effect allele G frequency of 0.9989. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs73471216'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_17737028', 'SNP': 'rs73471216', 'effect_allele': 'A', 'effect_allele_frequency': 0.0011, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9989}] | general | Select, Calculate | Allele Frequency |
Q3.1639 | Q3 | What is the allele frequency of the SNP rs139499244 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs139499244 has an effect allele T frequency of 0.0257 and non-effect allele C frequency of 0.9743. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs139499244'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_17505018', 'SNP': 'rs139499244', 'effect_allele': 'T', 'effect_allele_frequency': 0.0257, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9742999999999999}] | general | Select, Calculate | Allele Frequency |
Q3.523 | Q3 | What is the allele frequency of the SNP rs142789910 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs142789910 has an effect allele C frequency of 0.0249 and non-effect allele A frequency of 0.9751. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs142789910'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_5432247', 'SNP': 'rs142789910', 'effect_allele': 'C', 'effect_allele_frequency': 0.0249, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9751}] | general | Select, Calculate | Allele Frequency |
Q3.1985 | Q3 | What is the allele frequency of the SNP rs184595739 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs184595739 has an effect allele T frequency of 0.0062 and non-effect allele C frequency of 0.9938. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs184595739'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_21068843', 'SNP': 'rs184595739', 'effect_allele': 'T', 'effect_allele_frequency': 0.0062, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9938}] | general | Select, Calculate | Allele Frequency |
Q3.1078 | Q3 | What is the allele frequency of the SNP rs145793190 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs145793190 has an effect allele C frequency of 0.0022 and non-effect allele T frequency of 0.9978. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs145793190'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_11440798', 'SNP': 'rs145793190', 'effect_allele': 'C', 'effect_allele_frequency': 0.0021999999999999, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9978000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.482 | Q3 | What is the allele frequency of the SNP rs192909594 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs192909594 has an effect allele G frequency of 0.0041 and non-effect allele A frequency of 0.9959. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs192909594'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_5010686', 'SNP': 'rs192909594', 'effect_allele': 'G', 'effect_allele_frequency': 0.0040999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9959000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.160 | Q3 | What is the allele frequency of the SNP rs6541306 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs6541306 has an effect allele T frequency of 0.3567 and non-effect allele C frequency of 0.6433. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs6541306'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_1529376', 'SNP': 'rs6541306', 'effect_allele': 'T', 'effect_allele_frequency': 0.3567, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.6433}] | general | Select, Calculate | Allele Frequency |
Q3.1253 | Q3 | What is the allele frequency of the SNP rs762242218 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs762242218 has an effect allele T frequency of 0.0014 and non-effect allele C frequency of 0.9986. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs762242218'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_13257830', 'SNP': 'rs762242218', 'effect_allele': 'T', 'effect_allele_frequency': 0.0014, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9986}] | general | Select, Calculate | Allele Frequency |
Q3.1205 | Q3 | What is the allele frequency of the SNP rs77702115 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs77702115 has an effect allele A frequency of 0.0013 and non-effect allele G frequency of 0.9987. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs77702115'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_12839739', 'SNP': 'rs77702115', 'effect_allele': 'A', 'effect_allele_frequency': 0.0013, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9987}] | general | Select, Calculate | Allele Frequency |
Q3.17 | Q3 | What is the allele frequency of the SNP rs138126448 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs138126448 has an effect allele T frequency of 0.0037 and non-effect allele C frequency of 0.9963. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs138126448'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_283034', 'SNP': 'rs138126448', 'effect_allele': 'T', 'effect_allele_frequency': 0.0037, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9963}] | general | Select, Calculate | Allele Frequency |
Q3.1550 | Q3 | What is the allele frequency of the SNP rs8004380 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs8004380 has an effect allele A frequency of 0.0009 and non-effect allele G frequency of 0.9991. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs8004380'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_16570871', 'SNP': 'rs8004380', 'effect_allele': 'A', 'effect_allele_frequency': 0.0009, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9991}] | general | Select, Calculate | Allele Frequency |
Q3.1081 | Q3 | What is the allele frequency of the SNP rs4449823 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs4449823 has an effect allele C frequency of 0.0016 and non-effect allele T frequency of 0.9984. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs4449823'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_11453047', 'SNP': 'rs4449823', 'effect_allele': 'C', 'effect_allele_frequency': 0.0016, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9984}] | general | Select, Calculate | Allele Frequency |
Q3.1972 | Q3 | What is the allele frequency of the SNP rs541526996 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs541526996 has an effect allele T frequency of 0.0008 and non-effect allele G frequency of 0.9992. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs541526996'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_20938217', 'SNP': 'rs541526996', 'effect_allele': 'T', 'effect_allele_frequency': 0.0008, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9992}] | general | Select, Calculate | Allele Frequency |
Q3.552 | Q3 | What is the allele frequency of the SNP rs746556978 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs746556978 has an effect allele G frequency of 0.0007 and non-effect allele A frequency of 0.9993. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs746556978'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_5729539', 'SNP': 'rs746556978', 'effect_allele': 'G', 'effect_allele_frequency': 0.0007, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9993}] | general | Select, Calculate | Allele Frequency |
Q3.1554 | Q3 | What is the allele frequency of the SNP rs12897201 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs12897201 has an effect allele C frequency of 0.2869 and non-effect allele T frequency of 0.7131. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs12897201'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_16632056', 'SNP': 'rs12897201', 'effect_allele': 'C', 'effect_allele_frequency': 0.2869, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.7131000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.665 | Q3 | What is the allele frequency of the SNP rs10940156 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs10940156 has an effect allele A frequency of 0.2527 and non-effect allele G frequency of 0.7473. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs10940156'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_6949297', 'SNP': 'rs10940156', 'effect_allele': 'A', 'effect_allele_frequency': 0.2527, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.7473000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.1626 | Q3 | What is the allele frequency of the SNP rs144057016 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs144057016 has an effect allele T frequency of 0.0004 and non-effect allele C frequency of 0.9996. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs144057016'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_17384998', 'SNP': 'rs144057016', 'effect_allele': 'T', 'effect_allele_frequency': 0.0004, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9996}] | general | Select, Calculate | Allele Frequency |
Q3.1028 | Q3 | What is the allele frequency of the SNP rs114424632 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs114424632 has an effect allele T frequency of 0.002 and non-effect allele C frequency of 0.998. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs114424632'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_10999244', 'SNP': 'rs114424632', 'effect_allele': 'T', 'effect_allele_frequency': 0.002, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.998}] | general | Select, Calculate | Allele Frequency |
Q3.1994 | Q3 | What is the allele frequency of the SNP rs144586668 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs144586668 has an effect allele G frequency of 0.0081 and non-effect allele A frequency of 0.9919. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs144586668'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_21116190', 'SNP': 'rs144586668', 'effect_allele': 'G', 'effect_allele_frequency': 0.0080999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9919000000000001}] | general | Select, Calculate | Allele Frequency |
Q3.1519 | Q3 | What is the allele frequency of the SNP rs7997002 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs7997002 has an effect allele A frequency of 0.4631 and non-effect allele C frequency of 0.5369. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs7997002'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_16322140', 'SNP': 'rs7997002', 'effect_allele': 'A', 'effect_allele_frequency': 0.4631, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.5368999999999999}] | general | Select, Calculate | Allele Frequency |
Q3.968 | Q3 | What is the allele frequency of the SNP rs571378508 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs571378508 has an effect allele A frequency of 0.0021 and non-effect allele G frequency of 0.9979. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs571378508'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_10391852', 'SNP': 'rs571378508', 'effect_allele': 'A', 'effect_allele_frequency': 0.0021, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9979}] | general | Select, Calculate | Allele Frequency |
Q3.1883 | Q3 | What is the allele frequency of the SNP rs73080045 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs73080045 has an effect allele G frequency of 0.0811 and non-effect allele A frequency of 0.9189. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs73080045'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_20163150', 'SNP': 'rs73080045', 'effect_allele': 'G', 'effect_allele_frequency': 0.0810999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9189}] | general | Select, Calculate | Allele Frequency |
Q3.287 | Q3 | What is the allele frequency of the SNP rs74956698 in an Alzheimer's disease study within a European cohort? | According to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022), single nucleotide polymorphism rs74956698 has an effect allele T frequency of 0.0011 and non-effect allele G frequency of 0.9989. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1 - freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.AlzheimerDisease_CombinedGeneData_UUID`
WHERE SNP = 'rs74956698'
LIMIT 1 | [{'UUID': 'AD_combo_gene_notext_UUID_2805084', 'SNP': 'rs74956698', 'effect_allele': 'T', 'effect_allele_frequency': 0.0011, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9989}] | general | Select, Calculate | Allele Frequency |
Q34.1943 | Q34 | What are the names of the genes that are targeted by the drug Voclosporin in the treatment of lupus nephritis? | In the context of lupus nephritis, the drug Voclosporin targets the gene protein phosphatase 3 catalytic subunit alpha. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%lupus nephritis%" OR LOWER(efo_term) LIKE "%lupus nep... | [{'UUID': 'DrugTargetsIndication121923_text_1192227', 'drugName': 'Voclosporin', 'tradeNames_list': "['Lupkynis']", 'syns_list': "['ISA-247', 'ISA247', 'ISATX-247', 'ISATX247', 'LX-211', 'LX211', 'Voclosporin']", 'yearOfFirstApproval': 2021, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Lupus Nephritis', 'efo_term': 'lupu... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1008 | Q34 | What are the names of the genes that are targeted by the drug Ipratropium Bromide in the treatment of Bronchospasm? | In the context of Bronchospasm, the drug Ipratropium Bromide targets the gene cholinergic receptor muscarinic 3. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%bronchospasm%" OR LOWER(efo_term) LIKE "%bronchospasm... | [{'UUID': 'DrugTargetsIndication121923_text_857474', 'drugName': 'Ipratropium Bromide', 'tradeNames_list': "['Atrovent', 'Atrovent aerocaps', 'Atrovent fte', 'Atrovent hfaAtrovent udvs', 'Ipratrop', 'Ipratrop steripoule', 'Ipratropium bromideRespontin', 'Rinatec', 'Tropiovent']", 'syns_list': "['Ipratropium bromide', '... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.57 | Q34 | What are the names of the genes that are targeted by the drug Lurasidone Hydrochloride in the treatment of bipolar I disorder? | In the context of bipolar I disorder, the drug Lurasidone Hydrochloride targets the gene dopamine receptor D2 and 5-hydroxytryptamine receptor 2A. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%bipolar i disorder%" OR LOWER(efo_term) LIKE "%bipola... | [{'UUID': 'DrugTargetsIndication121923_text_197914', 'drugName': 'Lurasidone Hydrochloride', 'tradeNames_list': "['Latuda']", 'syns_list': "['Lurasidone hcl', 'Lurasidone hydrochloride', 'SM-13496']", 'yearOfFirstApproval': 2010, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Bipolar Disorder', 'efo_term': 'bipolar I disor... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1439 | Q34 | What are the names of the genes that are targeted by the drug Amlodipine Benzoate in the treatment of hypertension? | In the context of hypertension, the drug Amlodipine Benzoate targets the gene calcium voltage-gated channel subunit alpha1 C, calcium voltage-gated channel subunit alpha1 S, calcium voltage-gated channel subunit alpha1 D and calcium voltage-gated channel subunit alpha1 F. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%hypertension%" OR LOWER(efo_term) LIKE "%hypertension... | [{'UUID': 'DrugTargetsIndication121923_text_1044026', 'drugName': 'Amlodipine Benzoate', 'tradeNames_list': "['Katerzia']", 'syns_list': "['Amlodipine benzoate']", 'yearOfFirstApproval': 2019, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Hypertension', 'efo_term': 'hypertension', 'approvedSymbol': 'CACNA1C', 'approvedNam... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1129 | Q34 | What are the names of the genes that are targeted by the drug Cobimetinib in the treatment of neoplasm? | In the context of neoplasm, the drug Cobimetinib targets the gene mitogen-activated protein kinase kinase 2 and mitogen-activated protein kinase kinase 1. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%neoplasm%" OR LOWER(efo_term) LIKE "%neoplasm%") AND ... | [{'UUID': 'DrugTargetsIndication121923_text_927356', 'drugName': 'Cobimetinib', 'tradeNames_list': "['Cotellic']", 'syns_list': "['Cobimetinib', 'GDC-0973', 'Gdc 0623', 'Gdc 0973', 'Gdc-0623', 'RG 7420RG-7420', 'RG7420', 'Rg-7420', 'Rg-7421', 'XL-518', 'Xl 518', 'Xl518']", 'yearOfFirstApproval': 2015, 'max_phase_for_in... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.875 | Q34 | What are the names of the genes that are targeted by the drug Diclofenac Sodium in the treatment of pain? | In the context of pain, the drug Diclofenac Sodium targets the gene prostaglandin-endoperoxide synthase 2 and prostaglandin-endoperoxide synthase 1. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%pain%" OR LOWER(efo_term) LIKE "%pain%") AND (LOWER(d... | [{'UUID': 'DrugTargetsIndication121923_text_836631', 'drugName': 'Diclofenac Sodium', 'tradeNames_list': "['Acoflam', 'Acoflam ret', 'Acoflam sr', 'Arthronac', 'Arthrotec 50Arthrotec 75', 'Closteril 100', 'Defanac', 'Defanac retard', 'Defanac srDexomon ret', 'Dexomon sr', 'Diclofenac sodium', 'DicloflexDicloflex ret', ... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.710 | Q34 | What are the names of the genes that are targeted by the drug Nilotinib in the treatment of neoplasm? | In the context of neoplasm, the drug Nilotinib targets the gene ABL proto-oncogene 1, non-receptor tyrosine kinase and BCR activator of RhoGEF and GTPase. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%neoplasm%" OR LOWER(efo_term) LIKE "%neoplasm%") AND ... | [{'UUID': 'DrugTargetsIndication121923_text_746682', 'drugName': 'Nilotinib', 'tradeNames_list': "['Tasigna']", 'syns_list': "['AMN 107', 'AMN-107', 'AMN107', 'NSC-747599', 'Nilotinib']", 'yearOfFirstApproval': 2007, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Neoplasms', 'efo_term': 'neoplasm', 'approvedSymbol': 'ABL1'... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.589 | Q34 | What are the names of the genes that are targeted by the drug Carbamazepine in the treatment of bipolar I disorder? | In the context of bipolar I disorder, the drug Carbamazepine targets the gene sodium voltage-gated channel alpha subunit 1, sodium voltage-gated channel alpha subunit 5, sodium voltage-gated channel alpha subunit 4, sodium voltage-gated channel alpha subunit 7, sodium voltage-gated channel alpha subunit 2, sodium volta... | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%bipolar i disorder%" OR LOWER(efo_term) LIKE "%bipola... | [{'UUID': 'DrugTargetsIndication121923_text_650986', 'drugName': 'Carbamazepine', 'tradeNames_list': "['Arbil mr', 'Carbagen sr', 'Carbamazepine', 'Carbatrol', 'Carnexiv', 'EpimazEpimaz ret', 'Epitol', 'Equetro', 'Sirtal ret', 'Tegretol', 'Tegretol XrTegretol chewtab', 'Tegretol prolonged release', 'Tegretol-xr', 'Teri... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1782 | Q34 | What are the names of the genes that are targeted by the drug Zoledronic Acid in the treatment of bone disease? | In the context of bone disease, the drug Zoledronic Acid targets the gene farnesyl diphosphate synthase. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%bone disease%" OR LOWER(efo_term) LIKE "%bone disease... | [{'UUID': 'DrugTargetsIndication121923_text_1099769', 'drugName': 'Zoledronic Acid', 'tradeNames_list': "['Aclasta', 'Reclast', 'Zerlinda', 'Zoledronic acid', 'Zometa']", 'syns_list': "['AK-156', 'Anhydrous zoledronic acid', 'CGP 42446', 'CGP-42446', 'CGP-42446ANSC-721517', 'Zoladrona acid mylan', 'Zoledronate', 'Zoled... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.985 | Q34 | What are the names of the genes that are targeted by the drug Trilaciclib Dihydrochloride in the treatment of small cell lung carcinoma? | In the context of small cell lung carcinoma, the drug Trilaciclib Dihydrochloride targets the gene cyclin dependent kinase 4 and cyclin dependent kinase 6. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%small cell lung carcinoma%" OR LOWER(efo_term) LIKE "... | [{'UUID': 'DrugTargetsIndication121923_text_851297', 'drugName': 'Trilaciclib Dihydrochloride', 'tradeNames_list': "['Cosela']", 'syns_list': "['Trilaciclib dihydrochloride']", 'yearOfFirstApproval': 2021, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Small Cell Lung Carcinoma', 'efo_term': 'small cell lung carcinoma', 'a... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.443 | Q34 | What are the names of the genes that are targeted by the drug Epinephrine in the treatment of glaucoma? | In the context of glaucoma, the drug Epinephrine targets the gene adrenoceptor alpha 1A, adrenoceptor beta 2, adrenoceptor beta 1, adrenoceptor beta 3, adrenoceptor alpha 1D, adrenoceptor alpha 1B, adrenoceptor alpha 2A, adrenoceptor alpha 2C and adrenoceptor alpha 2B. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%glaucoma%" OR LOWER(efo_term) LIKE "%glaucoma%") AND ... | [{'UUID': 'DrugTargetsIndication121923_text_361089', 'drugName': 'Epinephrine', 'tradeNames_list': "['Adren co', 'Adrenaclick', 'Adrenalin', 'Ana-Kit', 'Ana-guard', 'AnapenAnaphylactic shock drug kit', 'Asma-vydrin', 'Asthmahaler', 'Auvi-qBronkaid mist', 'Brovon', 'Emerade', 'Epi e z pen jr', 'EpinephrineEpinephrine (c... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1873 | Q34 | What are the names of the genes that are targeted by the drug Lenalidomide in the treatment of anemia? | In the context of anemia, the drug Lenalidomide targets the gene cereblon, damage specific DNA binding protein 1, cullin 4A and ring-box 1. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%anemia%" OR LOWER(efo_term) LIKE "%anemia%") AND (LOW... | [{'UUID': 'DrugTargetsIndication121923_text_1105913', 'drugName': 'Lenalidomide', 'tradeNames_list': "['Revlimid']", 'syns_list': "['CC-5013', 'CDC-501', 'Lenalidomide', 'NSC-747972', 'SYP-1512']", 'yearOfFirstApproval': 2005, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Anemia', 'efo_term': 'anemia', 'approvedSymbol': '... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.70 | Q34 | What are the names of the genes that are targeted by the drug Cariprazine Hydrochloride in the treatment of bipolar disorder? | In the context of bipolar disorder, the drug Cariprazine Hydrochloride targets the gene dopamine receptor D2 and dopamine receptor D3. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%bipolar disorder%" OR LOWER(efo_term) LIKE "%bipolar ... | [{'UUID': 'DrugTargetsIndication121923_text_199881', 'drugName': 'Cariprazine Hydrochloride', 'tradeNames_list': "['Vraylar']", 'syns_list': "['Cariprazine hcl', 'Cariprazine hydrochloride', 'RGH-188 HCL']", 'yearOfFirstApproval': 2015, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Bipolar Disorder', 'efo_term': 'bipolar ... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1915 | Q34 | What are the names of the genes that are targeted by the drug Teduglutide in the treatment of primary short bowel syndrome? | In the context of primary short bowel syndrome, the drug Teduglutide targets the gene glucagon like peptide 2 receptor. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%primary short bowel syndrome%" OR LOWER(efo_term) LIK... | [{'UUID': 'DrugTargetsIndication121923_text_1149494', 'drugName': 'Teduglutide', 'tradeNames_list': "['Gattex kit']", 'syns_list': "['ALX 0600', 'ALX-0600', 'Gattex', 'Revestive', 'TeduglutideTeduglutide (rdna origin)', 'Teduglutide recombinant']", 'yearOfFirstApproval': 2012, 'max_phase_for_ind': 4.0, 'mesh_heading': ... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.72 | Q34 | What are the names of the genes that are targeted by the drug Cariprazine Hydrochloride in the treatment of schizophrenia? | In the context of schizophrenia, the drug Cariprazine Hydrochloride targets the gene dopamine receptor D2 and dopamine receptor D3. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%schizophrenia%" OR LOWER(efo_term) LIKE "%schizophren... | [{'UUID': 'DrugTargetsIndication121923_text_199891', 'drugName': 'Cariprazine Hydrochloride', 'tradeNames_list': "['Vraylar']", 'syns_list': "['Cariprazine hcl', 'Cariprazine hydrochloride', 'RGH-188 HCL']", 'yearOfFirstApproval': 2015, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Schizophrenia', 'efo_term': 'schizophren... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1759 | Q34 | What are the names of the genes that are targeted by the drug Lansoprazole in the treatment of gastroesophageal reflux disease? | In the context of gastroesophageal reflux disease, the drug Lansoprazole targets the gene ATPase H+/K+ transporting subunit alpha and ATPase H+/K+ transporting subunit beta. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%gastroesophageal reflux disease%" OR LOWER(efo_term) ... | [{'UUID': 'DrugTargetsIndication121923_text_1098431', 'drugName': 'Dexlansoprazole', 'tradeNames_list': "['Dexilant', 'Dexilant solutab', 'Kapidex']", 'syns_list': "['(r)-lansoprazole', 'Dexlansoprazole', 'Kapidex', 'Lansoprazole r-formLansoprazole, (r)-', 'NSC-758710', 'T-168390', 'TAK-390']", 'yearOfFirstApproval': 2... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.604 | Q34 | What are the names of the genes that are targeted by the drug Eslicarbazepine Acetate in the treatment of Seizure? | In the context of Seizure, the drug Eslicarbazepine Acetate targets the gene sodium voltage-gated channel alpha subunit 1, sodium voltage-gated channel alpha subunit 5, sodium voltage-gated channel alpha subunit 4, sodium voltage-gated channel alpha subunit 7, sodium voltage-gated channel alpha subunit 2, sodium voltag... | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%seizure%" OR LOWER(efo_term) LIKE "%seizure%") AND (L... | [{'UUID': 'DrugTargetsIndication121923_text_656750', 'drugName': 'Eslicarbazepine Acetate', 'tradeNames_list': "['Aptiom', 'Erelib', 'Pazzul', 'Stedesa', 'Zebinix']", 'syns_list': "['BIA 2-093', 'BIA-2-093', 'BIA-2093', 'Eslicarbazepine acetateSEP - 0002093', 'SEP-0002093']", 'yearOfFirstApproval': 2009, 'max_phase_for... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1794 | Q34 | What are the names of the genes that are targeted by the drug Nizatidine in the treatment of Peptic ulcer? | In the context of Peptic ulcer, the drug Nizatidine targets the gene histamine receptor H2. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%peptic ulcer%" OR LOWER(efo_term) LIKE "%peptic ulcer... | [{'UUID': 'DrugTargetsIndication121923_text_1100308', 'drugName': 'Nizatidine', 'tradeNames_list': "['Axid', 'Axid ar', 'Nizatidine', 'Zinga 150', 'Zinga 300']", 'syns_list': "['Acinon', 'LY 139037', 'LY-139037', 'NSC-759289', 'Nizatidine']", 'yearOfFirstApproval': 1988, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Pepti... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1793 | Q34 | What are the names of the genes that are targeted by the drug Dantrolene Sodium in the treatment of multiple sclerosis? | In the context of multiple sclerosis, the drug Dantrolene Sodium targets the gene ryanodine receptor 3 and ryanodine receptor 1. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%multiple sclerosis%" OR LOWER(efo_term) LIKE "%multip... | [{'UUID': 'DrugTargetsIndication121923_text_1100268', 'drugName': 'Dantrolene Sodium', 'tradeNames_list': "['Dantrium', 'Dantrolene sodium', 'Revonto', 'Ryanodex']", 'syns_list': "['Dantamacrin', 'Dantrolen', 'Dantrolene sodiumDantrolene sodium heptahydrate', 'Dantrolene sodium hydrateDantrolene sodium salt hemiheptahy... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.309 | Q34 | What are the names of the genes that are targeted by the drug Dexamethasone in the treatment of nephrotic syndrome? | In the context of nephrotic syndrome, the drug Dexamethasone targets the gene nuclear receptor subfamily 3 group C member 1. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%nephrotic syndrome%" OR LOWER(efo_term) LIKE "%nephro... | [{'UUID': 'DrugTargetsIndication121923_text_227764', 'drugName': 'Dexamethasone', 'tradeNames_list': "['Aeroseb-dex', 'Dalalone', 'Decaderm', 'Decadron', 'Decadron-75', 'DecasprayDexacortisyl', 'Dexafree', 'Dexamethasone', 'Dexamethasone intensolDexone', 'Dexone 0.5', 'Dexone 0.75', 'Dexone 1.5', 'Dexone 4', 'DexsolDex... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1746 | Q34 | What are the names of the genes that are targeted by the drug Esomeprazole Magnesium in the treatment of gastroesophageal reflux disease? | In the context of gastroesophageal reflux disease, the drug Esomeprazole Magnesium targets the gene ATPase H+/K+ transporting subunit alpha and ATPase H+/K+ transporting subunit beta. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%gastroesophageal reflux disease%" OR LOWER(efo_term) ... | [{'UUID': 'DrugTargetsIndication121923_text_1097873', 'drugName': 'Esomeprazole Magnesium', 'tradeNames_list': "['Esomeprazole magnesium', 'Nexium', 'Nexium 24hr']", 'syns_list': "['Esomeprazole (as magnesium)', 'Esomeprazole magnesiumEsomeprazole magnesium hydrate', 'Esomeprazole magnesium trihydrateH199/18 MAGNESIUM ... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1315 | Q34 | What are the names of the genes that are targeted by the drug Riociguat in the treatment of pulmonary arterial hypertension? | In the context of pulmonary arterial hypertension, the drug Riociguat targets the gene guanylate cyclase 1 soluble subunit beta 1, guanylate cyclase 1 soluble subunit beta 2 (pseudogene), guanylate cyclase 1 soluble subunit alpha 2 and guanylate cyclase 1 soluble subunit alpha 1. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%pulmonary arterial hypertension%" OR LOWER(efo_term) ... | [{'UUID': 'DrugTargetsIndication121923_text_972939', 'drugName': 'Riociguat', 'tradeNames_list': "['Adempas', 'Bay 63-2521']", 'syns_list': "['BAY 63-2521', 'BAY-63-2521', 'Riociguat']", 'yearOfFirstApproval': 2013, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Familial Primary Pulmonary Hypertension', 'efo_term': 'idiopa... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1276 | Q34 | What are the names of the genes that are targeted by the drug Larotrectinib Sulfate in the treatment of neoplasm? | In the context of neoplasm, the drug Larotrectinib Sulfate targets the gene neurotrophic receptor tyrosine kinase 1, neurotrophic receptor tyrosine kinase 2 and neurotrophic receptor tyrosine kinase 3. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%neoplasm%" OR LOWER(efo_term) LIKE "%neoplasm%") AND ... | [{'UUID': 'DrugTargetsIndication121923_text_942606', 'drugName': 'Larotrectinib Sulfate', 'tradeNames_list': "['Vitrakvi']", 'syns_list': "['ARRY-470 SULFATE', 'LOXO-101 sulfate', 'Larotrectinib sulfate']", 'yearOfFirstApproval': 2018, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Neoplasm Metastasis', 'efo_term': 'metast... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1087 | Q34 | What are the names of the genes that are targeted by the drug Apalutamide in the treatment of cancer? | In the context of cancer, the drug Apalutamide targets the gene androgen receptor. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%cancer%" OR LOWER(efo_term) LIKE "%cancer%") AND (LOW... | [{'UUID': 'DrugTargetsIndication121923_text_921857', 'drugName': 'Apalutamide', 'tradeNames_list': "['Erleada']", 'syns_list': "['ARN-509', 'Apalutamide', 'Arn-509', 'JNJ-56021927']", 'yearOfFirstApproval': 2018, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Neoplasms', 'efo_term': 'cancer', 'approvedSymbol': 'AR', 'appro... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.655 | Q34 | What are the names of the genes that are targeted by the drug Desmopressin Acetate in the treatment of diabetes insipidus? | In the context of diabetes insipidus, the drug Desmopressin Acetate targets the gene arginine vasopressin receptor 2, arginine vasopressin receptor 1A and arginine vasopressin receptor 1B. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%diabetes insipidus%" OR LOWER(efo_term) LIKE "%diabet... | [{'UUID': 'DrugTargetsIndication121923_text_694421', 'drugName': 'Desmopressin Acetate', 'tradeNames_list': "['Concentraid', 'Ddavp', 'Ddavp (needs no refrigeration)', 'DesmomeltDesmopressin acetate', 'Desmopressin acetate (needs no refrigeration)Desmopressin acetate preservative free', 'Desmospray', 'DesmotabsMinirin'... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1834 | Q34 | What are the names of the genes that are targeted by the drug Plerixafor in the treatment of acute lymphoblastic leukemia? | In the context of acute lymphoblastic leukemia, the drug Plerixafor targets the gene C-X-C motif chemokine receptor 4. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%acute lymphoblastic leukemia%" OR LOWER(efo_term) LIK... | [{'UUID': 'DrugTargetsIndication121923_text_1103209', 'drugName': 'Plerixafor', 'tradeNames_list': "['Mozobil']", 'syns_list': "['AMD 3100', 'AMD3100', 'JM 3100', 'Plerixafor', 'Plerixafor hydrochloridePlerixafor octahydrochloride', 'SID 791']", 'yearOfFirstApproval': 2008, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Ly... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1339 | Q34 | What are the names of the genes that are targeted by the drug Capsaicin in the treatment of Muscle spasm? | In the context of Muscle spasm, the drug Capsaicin targets the gene transient receptor potential cation channel subfamily V member 1. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%muscle spasm%" OR LOWER(efo_term) LIKE "%muscle spasm... | [{'UUID': 'DrugTargetsIndication121923_text_993223', 'drugName': 'Capsaicin', 'tradeNames_list': "['Qutenza', 'Zacin', 'Zostrix', 'Zostrix hp']", 'syns_list': "['ALGRX 4975', 'ALGRX-4975', 'Ausanil', 'Axsain', 'Capsaicin', 'Capzasin-hpCntx-4975', 'Dolenon', 'FEMA NO. 3404', 'Mioton', 'NGX-1998', 'NGX-4010NSC-56353', 'N... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.683 | Q34 | What are the names of the genes that are targeted by the drug Infigratinib Phosphate in the treatment of cholangiocarcinoma? | In the context of cholangiocarcinoma, the drug Infigratinib Phosphate targets the gene fibroblast growth factor receptor 1, fibroblast growth factor receptor 3, fibroblast growth factor receptor 2 and fibroblast growth factor receptor 4. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%cholangiocarcinoma%" OR LOWER(efo_term) LIKE "%cholan... | [{'UUID': 'DrugTargetsIndication121923_text_708623', 'drugName': 'Infigratinib Phosphate', 'tradeNames_list': "['Truseltiq']", 'syns_list': "['BGJ-398 phosphate', 'Infigratinib monophosphate', 'Infigratinib phosphate']", 'yearOfFirstApproval': 2021, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Cholangiocarcinoma', 'efo_t... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1655 | Q34 | What are the names of the genes that are targeted by the drug Abiraterone Acetate in the treatment of prostate cancer? | In the context of prostate cancer, the drug Abiraterone Acetate targets the gene cytochrome P450 family 17 subfamily A member 1. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%prostate cancer%" OR LOWER(efo_term) LIKE "%prostate ... | [{'UUID': 'DrugTargetsIndication121923_text_1094288', 'drugName': 'Abiraterone Acetate', 'tradeNames_list': "['Yonsa', 'Zytiga']", 'syns_list': "['Abiraterone acetate', 'CB-7630', 'CB7630', 'NSC-748121', 'NSC-749227']", 'yearOfFirstApproval': 2011, 'max_phase_for_ind': 4.0, 'mesh_heading': 'Prostatic Neoplasms', 'efo_t... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1578 | Q34 | What are the names of the genes that are targeted by the drug Everolimus in the treatment of breast neoplasm? | In the context of breast neoplasm, the drug Everolimus targets the gene FKBP prolyl isomerase 1A. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%breast neoplasm%" OR LOWER(efo_term) LIKE "%breast ne... | [{'UUID': 'DrugTargetsIndication121923_text_1088734', 'drugName': 'Everolimus', 'tradeNames_list': "['Afinitor', 'Afinitor disperz', 'Certican', 'Votubia', 'Zortress']", 'syns_list': "['40-o-(2-hydroxyethyl)-rapamycin', 'Everolimus', 'RAD 666', 'RAD-001RAD-666', 'RAD001', 'SDZ-RAD', 'Sdz rad']", 'yearOfFirstApproval': ... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Q34.1900 | Q34 | What are the names of the genes that are targeted by the drug Latanoprost in the treatment of hypertension? | In the context of hypertension, the drug Latanoprost targets the gene prostaglandin F receptor. | SELECT DISTINCT UUID, drugName, tradeNames_list, syns_list, yearOfFirstApproval, max_phase_for_ind, mesh_heading, efo_term, approvedSymbol, approvedName
FROM `{project_id}.{dataset_name}.DrugTargets_IndicationsAndTherapeuticUses`
WHERE (LOWER(mesh_heading) LIKE "%hypertension%" OR LOWER(efo_term) LIKE "%hypertension... | [{'UUID': 'DrugTargetsIndication121923_text_1149119', 'drugName': 'Latanoprost', 'tradeNames_list': "['Latanoprost', 'Monopost', 'Xalatan', 'Xelpros']", 'syns_list': "['Latanoprost', 'Latanoprost (isopropyl ester)', 'PHXA-41', 'PHXA41', 'T-2345T2345', 'XA-41', 'XA41']", 'yearOfFirstApproval': 1996, 'max_phase_for_ind':... | general | Distinct, Multi-Filter, Similarity Search, Order By | Metadata |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.